Conversation With Family Doctor to Increase COVID-19 Vaccine Uptake
NCT ID: NCT05207137
Last Updated: 2025-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
654 participants
INTERVENTIONAL
2021-12-03
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vascular Lifestyle-Intervention and Screening in Pharmacy
NCT02223793
An Intervention to Reduce Inappropriate Prescriptions for Elderly Patients in General Practice
NCT00281450
Oslo Pharmacist Intervention Study - Effect on Readmissions
NCT02336113
Vaccination Nudges From Pharmacists
NCT07161739
Intravenous Antibiotic Treatment at Home
NCT04898452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telephone call from family physician
Individuals allocated to the experimental arm will receive a phone call from the their family physician, where they are offered the opportunity to raise questions they might have about the COVID-19 vaccine.
Telephone call about vaccination
Participants receive phone call from their family physician, where they are invited to ask questions about the COVID-19 vaccine.
Usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telephone call about vaccination
Participants receive phone call from their family physician, where they are invited to ask questions about the COVID-19 vaccine.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Institute of Public Health
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Atle Fretheim, PhD
Role: STUDY_DIRECTOR
Norwegian Institute of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bolteløkka legesenter
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tuv M, Elgersma IH, Furuseth E, Holst C, Helleve A, Fretheim A. GP phone calls to improve COVID-19 vaccine uptake among patients at increased risk of severe COVID-19: a randomised trial. BJGP Open. 2023 Jun 27;7(2):BJGPO.2022.0175. doi: 10.3399/BJGPO.2022.0175. Print 2023 Jun.
Related Links
Access external resources that provide additional context or updates about the study.
Main study report
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cristin-ID: 2526531
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.